GuidanceMHRA
Risk-Adapted Approach to clinical trials and Risk Assessments
The MHRA have implemented a dual strategy for a risk-adapted approach to clinical trials in the UK.
First published: Jan 28, 2022Last updated: Jan 28, 2022Changes: 1
Latest change: First published.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.